TP53 and mantle cell lymphoma: MCL pathophysiology is also marked by deletions or mutations in the ATM tumor suppressor gene, noted to be present in nearly half of all new MCL cases [16,17], as well as mutations in TP53, noted to be present in approximately 15% of new MCL cases [18,19].